Importance of KIM-1 and MCP-1 in Determining the Leptospirosis-Associated AKI: A Sri Lankan Study

Table 1

Clinical features of patients based on AKI status.

Clinical features	All cases ()			Confirmed diagnosis of leptospirosis ()			Without a confirmed diagnosis of leptospirosis ()
	AKI (%) ()	Non-AKI (%) ()	value	AKI (%) ()	Non-AKI (%) ()	value	AKI (%) ()	Non-AKI (%) ()	value
Fever	92.00	97.93	0.1062	89.47	100.00	0.0114	100.00	96.47	0.6416
Headache	48.00	66.20	0.0817	52.63	61.66	0.4875	33.33	69.41	0.0708
Myalgia	88.00	80.00	0.3461	94.73	83.33	0.2139	66.66	77.64	0.5396
Arthralgia	48.00	53.10	0.6383	42.10	55.00	0.3298	66.66	51.76	0.4823
Chills and rigors	52.00	45.51	0.5491	52.63	35.00	0.1729	50.00	52.94	0.8897
Lethargy	28.00	19.31	0.3224	26.31	20.00	0.5622	33.33	18.82	0.3911
Conjunctival suffusion	28.00	17.93	0.2411	26.31	20.00	0.5622	33.33	16.47	0.2971
Cough	28.00	38.62	0.3113	26.31	38.33	0.3429	33.33	38.82	0.7905
Dyspnea	16.00	7.58	0.1716	15.78	8.33	0.3512	16.66	7.05	0.3956
Nausea	24.00	20.68	0.7083	26.31	23.33	0.7924	16.66	18.82	0.8962
Vomiting	56.00	43.44	0.2453	52.63	45.00	0.5638	66.66	42.35	0.2489
Diarrhea	48.00	37.24	0.3094	47.36	30.00	0.1671	50.00	42.35	0.7159
Abdominal pain	20.00	31.03	0.2650	21.05	33.33	0.3135	16.66	29.41	0.5064
Icterus	32.00	13.79	0.0238	36.84	10.00	0.0063	16.66	16.47	0.9904
Anuria/oliguria	60.00	30.34	0.0041	68.42	35.00	0.0108	33.33	27.05	0.7405
Hematuria	48.00	25.51	0.0222	63.15	25.00	0.0024	0.00	25.88	0.1547

: two-sample proportion test.